glp 1 medications in pill form Are Pills the Next Big Thing for GLP-1 Drugs? GLP-1 Medications for Weight loss

Food and Drug Administration highlight ongoing shortages of essential neurological and CNS injectables

Wonderful Service

Melasma: How hormones can modulate skin pigmentation

But with the stock down 45% from its 52-week high, Novo Nordisk could be a strong turnaround opportunity in the GLP-1 space, given the long-term growth potential of GLP-1 drugs

What Mechanistic Evidence Can and Cannot Prove Rodent mechanistic findings support why the warning exists Human mechanistic data does not confirm a comparable risk pathway Therefore, the burden shifts to high-quality human data Bottom Line: If GLP-1 drugs caused MTC in humans like in rodents, we'd expect clearer biologic signals in human C-cells and biomarkers